Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
UBC acquired Examoto, a leading provider of FDA-mandated REMS compliance platforms and technology.
Learn MorePartnering with the biopharmaceutical industry to provide leading late stage and patient support services focused on patient safety, access, and value.
Real Data
Real People
Real Outcomes
Our customizable and innovative tools enhance UBC’s Global Late Stage, Safety, and Patient Support Services focusing on patient safety, data security, efficiency, quality, and product value.
Learn More
Article | July 28, 2022
UBC added to its best-in-class REMS services by acquiring REMS technology and platform provider Examoto, LLC.
Read More
Article | September 1, 2022
For newly diagnosed patients, Hub services provide a comprehensive partner and advocate for them throughout starting and adhering to their therapy.
Read More
Article | June 27, 2022
UBC was recognized for the second year in a row by Dr First in their Healthiverse Heroes awards.
Read MoreIf you are with a pharmaceutical or biotech company and seeking information on UBC services, please fill out the form below. For all other general inquires please message: contact@ubc.com
* required field
If you are with a pharmaceutical or biotech company and seeking information on UBC services, please fill out the form below.For all other general inquires please message: contact@ubc.com
* required field
